These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3513058)

  • 1. Distribution of neuropeptide Y immunoreactivity in the rat basal ganglia: effects of excitotoxin lesions to caudate-putamen.
    Christie MJ; Beart PM; Jarrott B; Maccarrone C
    Neurosci Lett; 1986 Jan; 63(3):305-9. PubMed ID: 3513058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.
    Dawbarn D; De Quidt ME; Emson PC
    Brain Res; 1985 Aug; 340(2):251-60. PubMed ID: 2862959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of haloperidol on immunoreactive neuropeptide Y in rat cerebral cortex and basal ganglia.
    Miyake M; Iguchi K; Okamura H; Fukui K; Nakajima T; Chihara K; Ibata Y; Yanaihara N
    Brain Res Bull; 1990 Aug; 25(2):263-9. PubMed ID: 2224539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution of substance P in the primate basal ganglia: an immunohistochemical study of baboon and human brain.
    Beach TG; McGeer EG
    Neuroscience; 1984 Sep; 13(1):29-52. PubMed ID: 6208509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of neuropeptide Y immunoreactivity in the basal forebrain and upper brainstem of the squirrel monkey (Saimiri sciureus).
    Smith Y; Parent A; Kerkérian L; Pelletier G
    J Comp Neurol; 1985 Jun; 236(1):71-89. PubMed ID: 3902914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical anticonvulsant activity of the excitatory amino acid N-methyl-D-aspartate in the rat caudate-putamen.
    Turski L; Meldrum BS; Cavalheiro EA; Calderazzo-Filho LS; Bortolotto ZA; Ikonomidou-Turski C; Turski WA
    Proc Natl Acad Sci U S A; 1987 Mar; 84(6):1689-93. PubMed ID: 3550795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study.
    Jessell TM; Emson PC; Paxinos G; Cuello AC
    Brain Res; 1978 Sep; 152(3):487-98. PubMed ID: 356929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions.
    Beal MF; Kowall NW; Swartz KJ; Ferrante RJ; Martin JB
    Synapse; 1989; 3(1):38-47. PubMed ID: 2563916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y distribution in human brain.
    Adrian TE; Allen JM; Bloom SR; Ghatei MA; Rossor MN; Roberts GW; Crow TJ; Tatemoto K; Polak JM
    Nature; 1983 Dec 8-14; 306(5943):584-6. PubMed ID: 6358901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of neuropeptide Y-like immunoreactivity in the brain of the lizard Gallotia galloti.
    Medina L; Martí E; Artero C; Fasolo A; Puelles L
    J Comp Neurol; 1992 May; 319(3):387-405. PubMed ID: 1602050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Fos-like immunoreactivity in the basal ganglia by ether anaesthesia: effects of injections of muscimol in rostral versus caudal substantia nigra pars reticulata.
    Shehab SA; Julyan TE
    Exp Brain Res; 2002 Jan; 142(2):227-40. PubMed ID: 11807577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colocalization of somatostatin, neuropeptide Y, and NADPH-diaphorase in the caudate-putamen of the rat.
    Rushlow W; Flumerfelt BA; Naus CC
    J Comp Neurol; 1995 Jan; 351(4):499-508. PubMed ID: 7721980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior to posterior variations in the concentration of somatostatin-like immunoreactivity in human basal ganglia.
    Davies P; Josef J; Thompson A
    Brain Res Bull; 1981 Oct; 7(4):365-8. PubMed ID: 6117352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic dopaminergic regulation of neuropeptide Y systems in discrete striatal and accumbens regions.
    Midgley LP; Wagstaff JD; Singh NA; Bush LG; Gibb JW; Hanson GR
    Eur J Pharmacol; 1994 Jan; 251(2-3):191-9. PubMed ID: 7908639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential distribution in rat basal ganglia of Met-enkephalin- and Met-enkephalin Arg6 Phe7-like peptides revealed by immunohistochemistry.
    Williams RG; Dockray GJ
    Brain Res; 1982 May; 240(1):167-70. PubMed ID: 7046877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEP-19 immunohistochemistry defines the basal ganglia and associated structures in the adult human brain, and is dramatically reduced in Huntington's disease.
    Utal AK; Stopka AL; Roy M; Coleman PD
    Neuroscience; 1998 Oct; 86(4):1055-63. PubMed ID: 9697113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of reserpine administration on neuropeptide Y immunoreactivity in the locus coeruleus and caudate-putamen nucleus of the rat brain.
    Smiałowska M; Legutko B
    Neuroscience; 1990; 36(2):411-5. PubMed ID: 1699165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems.
    Westwood SC; Hanson GR
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1160-6. PubMed ID: 10027854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y (NPY)-like immunoreactivity in rat sympathetic neurons and small granule-containing cells.
    Järvi R; Helén P; Pelto-Huikko M; Hervonen A
    Neurosci Lett; 1986 Jun; 67(2):223-7. PubMed ID: 2873536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.